Wild-type ribonuclease A and five mutants thereof have been expressed in Eseherichia coil as fusion proteins by using a l7 expression system. The five mutants are Bovine pancreatic ribonuclease A (RNase A) has been used as a model system to investigate the pathways of protein folding and the role played by the disulfide bonds in the regeneration of the native protein from the reduced form (1-13). Such studies could be facilitated by recombinant DNA methods to introduce 15N or 13C labels for multidimensional NMR spectroscopic studies of trapped intermediates along the folding pathways. In addition, by replacing each of the native disulfide-forming cysteine pairs, in turn, it is possible to obtain material to investigate the influence ofeach disulfide bond on the thermal stability of the protein. This methodology can also be used to introduce mutations in other regions of the polypeptide chain to study features of the folding process-e.g., the role of cis-trans isomerization about peptide bonds preceding proline (14) or the interactions that other residues contribute in forming chain-folding initiation sites (15) and in stabilizing folding intermediates. Breslow et al. (16) have developed cyclodextrin mimics of ribonuclease involving only histidines, and no lysine, in the catalysis of RNA. However, Lys4l has previously been thought to be involved in catalysis by increasing the electrophilicity of the phosphorous and stabilizing a trigonal bipyramidal intermediate (ref. 17, p. 432). In addition, selective
Bovine pancreatic ribonuclease A (RNase A) has been used as a model system to investigate the pathways of protein folding and the role played by the disulfide bonds in the regeneration of the native protein from the reduced form (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) . Such studies could be facilitated by recombinant DNA methods to introduce 15N or 13C labels for multidimensional NMR spectroscopic studies of trapped intermediates along the folding pathways. In addition, by replacing each of the native disulfide-forming cysteine pairs, in turn, it is possible to obtain material to investigate the influence ofeach disulfide bond on the thermal stability of the protein. This methodology can also be used to introduce mutations in other regions of the polypeptide chain to study features of the folding process-e.g., the role of cis-trans isomerization about peptide bonds preceding proline (14) or the interactions that other residues contribute in forming chain-folding initiation sites (15) and in stabilizing folding intermediates. Breslow (18) , has been shown to inactivate the enzyme. Therefore, it is ofinterest to mutate Lys4l and examine the catalytic properties of this enzyme.
For these reasons, we have developed an efficient expression system to produce mutants of RNase A with which to investigate the structural and functional features of this enzyme.
Several expression systems for RNase A have been developed previously (14, (19) (20) (21) (22) . Some of these systems direct the export of the target protein to the periplasmic space or even to the extracellular medium (unpublished observations; refs. 19 and 20) . These secretion systems produce authentic recombinant RNase A with the correct N-terminal sequence but require that the expressed protein be folded in vivo. Therefore, mutations of amino acids which are important in stabilizing the folding protein result in low expression yields. In addition, expression systems that produce folded, active RNase A, even when directed to the extracellular medium or periplasmic space, have been observed to give extremely low yields, presumably because of the inherent toxicity of active RNase A (unpublished results). Other systems express the target protein in the cytosol, modified with a methionine at the N terminus, but again, such active RNase A is likely to be produced in very low yields. The formation of inclusion bodies protects the expressed RNase A from degradation by intracellular proteolysis. However, inclusion bodies have to be solubilized in either folded or unfolded form in order to be purified.
Here, cysteines were blocked reversibly with a sulfonating reagent that can prevent formation ofintermolecular disulfide bonds or aggregation of unfolded wild-type or mutant RNase A. In this paper, we present a procedure to obtain pure, unfolded recombinant RNase A with the correct N-terminal sequence. This material is obtained from a factor Xacleavable fusion protein with a modified T7 gene 10 protein that is expressed in intracellular inclusion bodies. This system provides high-level expression of mutant RNase A in an unaggregated and unfolded form. Since the ability to refold wild-type sulfonated RNase A (SO3-RNase A) quantitatively has been well documented (13, 23) heim. Control nonrecombinant RNase A from Sigma was purified further on a column packed with S-Sepharose (Pharmacia) resin. HPLC columns were obtained from Pharmacia LKB.
Construction of Expression Vector. A plasmid was constructed to express RNase A as a fusion protein with a gene 10 protein by using pGEMEX-2, which utilizes a T7 expression system (25) . A synthetic RNase A gene was originally cloned into the multiple cloning site of an M13 replicativeform bacteriophage vector from pGX22314 (a vector obtained from Genex). A factor Xa site was then introduced directly in front of the synthetic RNase A gene by oligonucleotidedirected mutagenesis, to create M13sj142. This gene was then subcloned from M13sj142 into the multiple cloning site of a modified pGEMEX-2 vector at the EcoRI/HindIII site, in frame and directly behind the gene coding for the T7 gene 10-II protein (Fig. 1) . Two minor factor Xa recognition sites in gene 10 with the sequence Gly-Arg-Xaa (Arge6 and Arg279)
were changed in pGEMEX-2 to Gly-Asp-Xaa by oligonucleotide-directed mutagenesis using phagemid-prepared singlestranded DNA as a template (the modified pGEMEX-2 is now called pSJIIGEM-2, and gene 10 is now called gene 10-1I) (Fig. 1 ). All subsequent mutants were constructed from the M13sj142 vector and subcloned into pSJIIGEM-2. All clones were sequenced by the dideoxy sequencing method with a kit from United States Biochemical.
Protein Expression. E. coli strain HMS174(DE3)-pLys(S) was used to express both wild-type and mutant fusion protein. This strain contains a plasmid, pLys(S), which directs the expression of T7 lysozyme, an inhibitor for T7 RNA polymerase (25) , to control the basal expression level of T7 RNA polymerase. Ten milliliters of LB medium containing ampicillin (100 ,ug/ml) and chloramphenicol (34 diluted to 1 liter and allowed to incubate under the same conditions. At OD600 = 0.4, expression of protein was induced by gradual addition of 0.5 mM isopropyl 8-Dthiogalactopyranoside over 2.5 hr. After 5-7 hr of further incubation (Fig. 2, lane 1) , the cells were harvested by centrifugation at 6000 rpm with a Beckman JA-10 rotor for 30 min. The cell pellets were then resuspended in 50 ml of lysis buffer (25 mM Tris.HCI/5 mM EDTA/2 mM phenylmethylsulfonyl fluoride, pH 8.0) (26) .
Isolation and Factor Xa Digestion. The resuspended cell pellet was sonicated, jacketed in ice, with 2-sec pulses for 5 min and then centrifuged at 6000 rpm for 45 min. The pellet was washed with 50 ml of 0.5% Triton X-100/1 mM EDTA, centrifuged at 7500 rpm for 1 hr, and then dissolved in 10 ml of 7 M guanidine-HCI/25 mM Tris-HCl/5 mM EDTA, pH 8.0. At this point, the pellet was -90%o overexpressed fusion protein, as judged by SDS/PAGE. All of the cysteines in this fusion protein were then sulfonated by the procedure of Thannhauser and Scheraga (23) . This solution was dialyzed against four changes of factor Xa digestion buffer (50 mM Tris.HCl/0.1 M NaCl, pH 7.0). During the dialysis, most of the sulfonated fusion protein formed a precipitate in the dialysis tube (Fig. 2 , lane 2). This precipitated protein solution was brought to 20 ml and digested with factor Xa in two steps. First, about 40-50 ,ug of factor Xa was added to the suspension and incubated with constant shaking for 14-18 hr at room temperature ( Fig. 2 , lanes 3 and 4). The supernatant was removed by centrifugation, and sufficient 10 M urea was added to make the supernatant -2 M and the pH was reduced to 4.0 with 1 M HCl. This solution was then saved for HPLC purification. Depending on the extent of digestion to this point, the resulting pellet was then resuspended in another 10-15 ml of digestion buffer to which another 10-30 ,g of factor Xa was added. This suspension was digested for another [12] [13] [14] [15] [16] hr, at which point the digestion of fusion protein was essentially complete (>90%) as judged by SDS/ PAGE. Immediately before centrifugation, sufficient 10 M urea and 1 M HCl were added to make the suspension -2 M in urea at a pH of 4.0, and to solubilize additional cleaved RNase A. This supernatant was also saved for HPLC purification.
Purificaton and Folding. The supernatant of the digestion mixture was purified on an HPLC cation-exchange column (Mono S HR5/5) with 25 mM formic acid/3 M urea at pH 4.0 with aNaCl gradient (Fig. 2, lane 5) . The solution ofwild-type or mutant RNase A collected from the HPLC column was exchanged into 2 mM EDTA/0.1 M Tris, pH 8.2, by using Pharmacia PD-b10 Sephadex G-25M columns, and then incubated in the presence of 1 mM/2 mM (oxidized/reduced) glutathione at 40C for 24-36 hr. With cyclic cytidine monophosphate (rCMP) as a substrate, the activity of regenerated wild-type S03-RNase A was used as a control to monitor the extent offolding. Once folding wasjudged to be complete, the pH ofthe recombinant folded protein was then adjusted to 5.0 with glacial acetic acid. This protein was then purified on a Mono S HR5/5 cation-exchange column with 20 mM Hepes at pH 7.0 with an NaCl gradient to remove any partially folded or mixed-disulfide intermediates with glutathione (Fig.  2, lane 6) .
Protein Concentration. The concentration of sulfonated unfolded mutant and wild-type RNase A was determined by using an extinction coefficient of 8500 M-1-cm-1 at 275 nm (23) . The concentration of folded mutant and wild-type protein was determined by using an extinction coefficient of 9800 M-l cm-l at 277.5 nm (27) .
Activity Measurements. (Figs. 1 and 3) , reducing the yield and complicating the purification considerably. The two factor Xa "minor sites" in gene 10 were assumed to be Gly67-Arg68-Xaa and Glyv78_Argm79Xa (32) . Therefore, the "minor sites" (A and B in Fig. 1 the engineered factor Xa site (Fig. 2, lanes 3 and 4) . Second, digestion of the sulfonated fusion protein as a suspension (50-80 mg in 20 ml) was found to be very efficient. As the digestion progressed, most of the S03-RNase A cleavage products became soluble, while the S03-gene 10 portion remained insoluble (Fig. 2, lanes 3 and 4) . The digestion time was kept to a minimum because factor Xa slowly degraded the cleaved S03-RNase A. In addition, the digestions were carried out at pH 7.0 instead of the recommended pH 8.0 (32, 33) , to minimize the deamidation of Asn67 (23) . No significant decrease in factor Xa activity was observed at pH 7.0 over the time period in which the sulfonated fusion protein was digested. Two problems during digestion were coprecipitation of cleaved S03-RNase A with S03-gene 10-II protein, and proteolytic degradation of cleaved S03-RNase A (Fig. 2,  lanes 3 and 4) . The temperature and incubation time for digestion presented here were optimized to obtain maximum cleavage and solubility of S03-RNase A while minimizing degradation. The addition of urea to the suspension after the second digestion solubilized most of the coprecipitated S03-RNase A without solubilizing significant amounts of the SO3-gene 10-II protein.
A Mono S HR5/5 cation exchange column (pH 4.0) with 3 M urea was used for purifying wild-type S03-RNase A and all subsequent mutants. The presence of urea prevented precipitation of sulfonated protein on the column. The purity of sulfonated protein after this purification step was >90%o as determined by SDS/PAGE (Fig. 2, lane 5) tEnzymatic activity relative to native nonrecombinant RNase A. Assay temperature was 250C, unless indicated otherwise. §Assay temperature was 100C. Assay was performed before Mono S purification at pH 7.0. Therefore, the activity of purified mutants, each with three native disulfides intact, is probably higher.
chromatograms of these mutants and were chromatographically removed.
The CD spectra (Fig. 4) 18 .50C and pH 5.9 (not shown) also indicated some compact structure resembling native RNase A. Specifically, the histidine C6H peaks appeared between 8.3 and 8.8 ppm and were resolved. The aromatic peaks also appeared to be resolved in a native-like pattern (at 6.5 to 7.5 ppm). Since the histidine peaks are very sensitive to their environment and pH, specific peak assignments could not be made with these spectra. However, the histidine and aromatic peaks of both thermally denatured disulfide-intact and S03-RNase A nearly coalesced (into one peak for the histidines and three peaks for the aromatics); this coalescence was not observed in the spectra of these mutants (ref. 23 Initially, in refolding buffer at 10°C, 21% and 8% activity relative to native was observed for C[58-110JS and C[26-84]S, respectively, indicating that these mutants probably have a native-like conformation at 10°C. However, this activity was lost when the assay was carried out at 25°C, indicating a low thermal stability for these mutants. Unfortunately, since we were unable to obtain appreciable recovery of folded C[58-1101S and C S from the Mono S column (<10%o recovery), further physical characterization was not carried out.
Folded K41G was isolated from a Mono S column with >50o recovery and was found to be thermally stable but inactive with cCMP as a substrate (Table 1 ). The CD spectrum of this mutant was very similar to that of wild-type RNase A (Fig. 4) . Finally, the one-dimensional 1H NMR spectrum of K41G at 18.5°C and pH 5.9 resembled that of folded wild-type RNase A, further indicating a compact folded structure for this mutant. DISCUSSION Expression. A versatile expression system for RNase A without modification with an N-terminal methionine has been presented here. Because most of the expressed RNase A-containing fusion protein forms inclusion bodies, this protein is protected from proteolytic degradation. As a result, the yields of all of the RNase A mutants were at least as high as wild type. In fact, the mutants which had significantly lower activity were obtained at higher expression levels (10-20%o higher efficiency. This corresponds to approximately 1:1000 (wt/wt) factor Xa/sulfonated fusion protein digested or 1:100 (wt/wt) factor Xa/purified S03-RNase A obtained (Table 1) , making this method economical in factor Xa for large-scale protein preparation. In addition, S03-RNase A became quite soluble once it was cleaved, and thus was obtained in a relatively pure form even prior to any chromatographic purification (Fig. 2, lane 4) .
It was previously reported that the minimum amino acid sequence required for factor Xa recognition and subsequent cleavage is Glu(Asp)-Gly-Arg-Xaa [the complete recognition sequence is Ile-Glu(Asp)-Gly-Arg-Xaa (32)]. Therefore, since the original pGEMEX-2 expression vector did not contain Glu(Asp)-Gly-Arg-Xaa but rather two Gly-Arg se-618 Biochemistry: Laity et al.
quences, both with a hydrophobic amino acid preceding Gly (either Leu66 or Val277), this vector was used initially. In contrast to the results obtained by Nagai and Th0gersen (32) , the fusion protein obtained from this original pGEMEX-2 expression vector exhibited significant factor Xa cleavage at these sites. In fact, both Gly-Arg-Xaa sites were cleaved competitively with the engineered complete factor Xa site (Fig. 3, lanes I and S) . This discrepancy between our results and those reported previously can probably be attributed, at least partially, to the inherent structure dependence of the substrate recognized by factor Xa, especially since the sulfonated fusion protein used here was unfolded and possibly more susceptible to cleavage by factor Xa. Also, variations in the preparations of factor Xa may also be a factor. Finally, the digestion time used here was significantly longer than that used by Nagai and Thogersen (32) . These results demonstrate that fusion proteins of low solubility can be digested with factor Xa with relatively good protein recoveries, but for these proteins the sequence restriction may be more stringent (e.g., no Gly-Arg-Xaa sequences in the fusion protein, especially in the desired conjugate). Fortunately, RNase A contains no Gly-Arg-Xaa sequence; hence, the removal of these "minor sites" from the gene 10 conjugate was entirely adequate.
Physical Since both the C[65-72]S and C[40-95]S three-disulfide mutants of RNase A are thermally stable above 30TC at pH 6.4, they are suitable for study by multidimensional NMR to elucidate their structure. The preliminary results in our laboratory suggest that the Tm values of these mutants at pH 4.5 are only 5°C lower (unpublished results) than the Tm values observed at pH 6.4. Low pH and higher temperature greatly improve the resolution achieved in multidimensional NMR studies. Finally, the three-disulfide mutants of RNase A with cysteine replaced by alanine have also been cloned for comparison with the serine mutants.
Since the K41G mutant has no enzymatic activity, the question arises as to whether the absence of activity is due to disruption of structure in the active site, inability of the substrate to bind to the active site, or loss of the required Lys41 for catalytic activity. Since glycine is much less bulky than lysine, it seems unlikely that the active site is distorted considerably, although the thermal transition curve of this mutant is quite broad (unpublished data) with a Tm that is 9°C lower than that of native RNase A (Table 1) . This difference in thermal transition temperature could also indicate that Lys41 has some structural role in the protein. In fact, the x-ray data (34) indicate that Lys41 forms a hydrogen bond with Asn". Also, replacement of the large lysine residue by the smaller glycine would be expected to lead to a change in the free-energy difference between the native and denatured states due to packing effects, even if no specific interactions are involved. However, the studies cited in the Introduction indicate that the most likely cause for the inactivation of RNase A by the Lys -* Gly mutation is either the loss of substrate-binding capability or the loss of catalytic function.
In conclusion, we have presented an efficient expression system that can produce large quantities of mutants of RNase A in an unaggregated stable unfolded form. If conformationally stable, these mutants can easily be folded. The preliminary characterization of the disulfide mutants as well as subsequent NMR and other studies to follow should help to elucidate the role that the disulfide bonds play in the folding and structure of RNase A.
